FDA Warns of Diabetes Rx Risk
The US Food and Drug Administration (FDA) has issued a safety announcement about the type 2 diabetes medication pioglitazone.
This Common Diabetes Rx May Be Safer Than Previously Thought
Weighing the benefits of medications against their potential risks is a common conundrum for many doctors. But, for one common diabetes medication, that decision may have gotten a little easier.
No Cancer Risk Found for Diabetes Rx
Worried about the health effects of the medications you take? There's likely no need to worry about two diabetes medications once thought to increase the risk of cancer.
Popular Diabetes Rx May Not Cut Bladder Cancer Risk
Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.
Diabetes May Indicate Risk of Bladder Cancer
People living with diabetes have a lot to think about. Managing the disease has its challenges. And with diabetes comes the risk of other health issues.
New Guidance on Actos or Takeda
If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.
Sales of Diabetes Drugs Stopped Due to Bladder Cancer Risks
Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.